Prancer RTSM vs YPrime IRT(RTSM / IRT)

Sponsors and CROs choosing a randomization and trial supply management (RTSM, also called IRT) system for interventional trials.

Scope Sponsors and CROs choosing an RTSM/IRT system to randomize participants and manage investigational product supply in interventional trials. Site-side pharmacy tools and stand-alone supply planning software are out of scope.

Guide updated How we compare

Compare within RTSM / IRT

Study fit, side by side

These notes describe the products in the RTSM / IRT guide.

Prancer RTSM

Best for
Sponsors and CROs with complex dosing or adaptive designs who want an RTSM specialist with supply forecasting
What to consider
4G Clinical is an RTSM specialist: Prancer covers randomization, resupply and direct-to-patient shipping, and 4C Supply adds portfolio-level forecasting. It publishes a SOC 2 Type 2 report and a Part 11 statement, and says it has supported more than 1,000 studies. It has no EDC or eCOA of its own, so plan for integrations.
Read product profile

YPrime IRT

Best for
Sponsors with complex randomization schemes, including minimization, who may also use YPrime eCOA
What to consider
YPrime names more randomization methods than any other vendor here, from permuted blocks to Pocock-Simon minimization, and publishes short build times. Its public IRT page does not describe supply forecasting or direct-to-patient shipping, and we found no named security certification.
Read product profile

Compare the features

Both products use the same category definitions. Product order is editorial; products are not ranked.

Full RTSM / IRT feature comparison

Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.

Expand a feature definition or support note for context and its original source.

Prancer RTSM vs YPrime IRT (RTSM / IRT): category feature evidence and sources. Products are not ranked.
Category featurePrancer RTSMYPrime IRT
Randomization and blinding
Feature definitions
Supported
Randomization or blinding workflows are stated.
Extended support
Named allocation methods include minimization or dynamic allocation.
Extended support

4G names stratification, cohort-specific logic, variable blocks and minimization, with versioned logic that protects blinding and handles re-randomization.

Source
About this support label

Named methods include variable blocks and minimization with blinding protection.

Extended support

YPrime names permuted block and stratified randomization, dynamic allocation and minimization (Pocock and Simon), stratum caps and conditional re-randomization.

Source
About this support label

Named methods include permuted blocks, dynamic allocation and minimization.

Trial supply management
Feature definitions
Supported
Drug inventory, dispensing, shipping or resupply workflows are documented.
Extended support
Supply forecasting and direct-to-patient delivery (shipping or dispensing) are both documented.
Extended support

Prancer handles dispensing and resupply with buffer-to-predictive forecasting and 4C Supply scenario modeling; direct-to-patient shipping was added in April 2020 (4G blog).

Source
About this support label

Predictive resupply, scenario modeling and direct-to-patient shipping are stated.

Supported

The IRT page covers inventory, orders, resupply, kit replacement and depot rules, but does not describe supply forecasting or direct-to-patient shipping.

Source
About this support label

Inventory and resupply establish base support; forecasting and direct-to-patient shipping are not described.

Study build speed and mid-study changes
Feature definitions
Supported
Study setup or post-go-live study changes are described.
Extended support
Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.
Supported

4G says its NLP-based build takes under four weeks, with specification sign-off to go-live in as little as 13 calendar days, and changes made without impacting study progress.

Source
About this support label

A build timeline and changes protecting study progress are stated; uninterrupted live use is not explicit.

Supported

YPrime cites build to go-live in under four weeks for an early-phase oncology trial, about a week for the simplest designs, and self-service routine changes that take effect immediately.

Source
About this support label

Build timelines and immediately effective routine changes are stated; uninterrupted live use is not explicit.

Integrations and platform
Feature definitions
Supported
Integration or data exchange with another system or application is described.
Extended support
Integration with a clinical-trial application plus an API for integration are both stated.
Supported

4G documents connections to EDC, CTMS, depot and logistics systems and data warehouses, but has no EDC or eCOA of its own and we found no public API reference.

Source
About this support label

Connections to trial systems establish base support; a public API reference was not found.

Supported

YPrime documents integrations with EDC, eCOA, eConsent, CTMS, labs, distribution systems and data lakes, and runs its own eCOA.

Source
About this support label

Trial-system integrations establish base support; an API is not stated in this note.

Compliance and security evidence
Feature definitions
Supported
Relevant trial compliance or security controls are stated, with their scope identified.
Extended support
Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
Supported

The trust center reports a SOC 2 Type 2 report for the 12 months ending 31 August 2026 and states compliance with 21 CFR Part 11 and EU Annex 11.

Source
About this support label

Trial standards and a dated SOC report period are stated; public report access is not established.

Supported

YPrime's trust page lists 21 CFR Part 11, GDPR and HIPAA compliance, but we found no ISO 27001 or SOC 2 attestation.

Source
About this support label

Trial and privacy standards are stated; ISO/SOC attestation evidence was not found.

Track record
Feature definitions
Supported
Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support
Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
Supported

4G says it has evolved to support more than a thousand studies worldwide.

Source
About this support label

Study adoption is reported worldwide, but no country count is given.

Supported

YPrime reports 55,000+ sites and 300,000+ patients supported and 20+ years of IRT work, but publishes no study count.

Source

The guide update date reflects guide edits. Vendor statements are attributed in the evidence.

Keep the category in view

Compare these products with the other tools in the RTSM / IRT guide using the same feature definitions.

More RTSM / IRT comparisons featuring one of these products.